Diagnostics outfit lays off third of employees, now looking at 'strategic alternatives'
A Lexington, MA-based diagnostics company has laid off nearly 30% of its employees as it searches for “strategic alternatives,” including a potential acquisition or merger.
T2 Biosystems, which specializes in blood tests but expanded to Covid-19 using upper respiratory samples, put out word on Tuesday that its restructuring efforts included a roughly 30% staff reduction completed last week. A spokesperson told Endpoints News that the layoffs impacted multiple departments, and that the current headcount is around 110 employees.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters